Use of simulect can reduce the incidence of acute rejection and demonstrates with superior 3-year patient and graft survival rates in renal transplantation

Chu S.-H.Chiang Y.-J.Huang C.-C.PO-HUANG LEEREY-HENG HULai M.-K.SHIH-CHIEH CHUEHMENG-KUN TSAI2021-08-022021-08-0220040041-1345https://www.scopus.com/inward/record.uri?eid=2-s2.0-7044285974&doi=10.1016%2fj.transproceed.2004.08.031&partnerID=40&md5=705b805712cdfb9d753ee1a1a3c8e6cahttps://scholars.lib.ntu.edu.tw/handle/123456789/575508Use of simulect can reduce the incidence of acute rejection and demonstrates with superior 3-year patient and graft survival rates in renal transplantationconference paper10.1016/j.transproceed.2004.08.031155187632-s2.0-7044285974